212 related articles for article (PubMed ID: 10530690)
1. Tiagabine.
Schachter SC
Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
[TBL] [Abstract][Full Text] [Related]
2. A review of the antiepileptic drug tiagabine.
Schachter SC
Clin Neuropharmacol; 1999; 22(6):312-7. PubMed ID: 10626090
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and clinical experience with tiagabine.
Schachter SC
Expert Opin Pharmacother; 2001 Jan; 2(1):179-87. PubMed ID: 11336578
[TBL] [Abstract][Full Text] [Related]
4. Tiagabine (gabitril) experience in children.
Pellock JM
Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
[TBL] [Abstract][Full Text] [Related]
5. Tiagabine monotherapy in the treatment of partial epilepsy.
Schachter SC
Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
[TBL] [Abstract][Full Text] [Related]
6. Tiagabine in clinical practice.
Genton P; Guerrini R; Perucca E
Epilepsia; 2001; 42 Suppl 3():42-5. PubMed ID: 11520322
[TBL] [Abstract][Full Text] [Related]
7. Tiagabine.
Schachter SC
Drugs Today (Barc); 1998 Mar; 34(3):283-9. PubMed ID: 15094857
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety of tiagabine.
Kälviäinen R
Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
[TBL] [Abstract][Full Text] [Related]
9. International experience with tiagabine add-on therapy.
Ben-Menachem E
Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
[TBL] [Abstract][Full Text] [Related]
10. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
[TBL] [Abstract][Full Text] [Related]
11. Tiagabine: a new therapeutic option for people with intellectual disability and partial epilepsy.
Kälviäinen R
J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():63-7. PubMed ID: 10030435
[TBL] [Abstract][Full Text] [Related]
12. Tiagabine: the safety landscape.
Leppik IE
Epilepsia; 1995; 36 Suppl 6():S10-S13. PubMed ID: 8595787
[TBL] [Abstract][Full Text] [Related]
13. Tiagabine.
Mengel H
Epilepsia; 1994; 35 Suppl 5():S81-4. PubMed ID: 8039477
[TBL] [Abstract][Full Text] [Related]
14. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
Adkins JC; Noble S
Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
[TBL] [Abstract][Full Text] [Related]
15. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
Chmielewska B; Stelmasiak Z
Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
[TBL] [Abstract][Full Text] [Related]
16. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
Loiseau P
Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics and indications of tiagabine].
Casas-Fernández C; Domingo-Jiménez R
Rev Neurol; 2002 Sep; 35 Suppl 1():S96-S100. PubMed ID: 12373661
[TBL] [Abstract][Full Text] [Related]
18. Tiagabine pharmacology in profile.
Brodie MJ
Epilepsia; 1995; 36 Suppl 6():S7-S9. PubMed ID: 8595791
[TBL] [Abstract][Full Text] [Related]
19. Effects of tiagabine monotherapy on abilities, adjustment, and mood.
Dodrill CB; Arnett JL; Shu V; Pixton GC; Lenz GT; Sommerville KW
Epilepsia; 1998 Jan; 39(1):33-42. PubMed ID: 9578010
[TBL] [Abstract][Full Text] [Related]
20. Population analysis of the pharmacokinetics of tiagabine in patients with epilepsy.
Samara EE; Gustavson LE; El-Shourbagy T; Locke C; Granneman GR; Sommerville KW
Epilepsia; 1998 Aug; 39(8):868-73. PubMed ID: 9701378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
